NSAIDs and cardiovascular risk

被引：0
|
作者：
Kotob, F [1 ]
de Leon-Casasola, OA [1 ]
Lema, MJ [1 ]
机构：
[1] SUNY Buffalo, Dept Anesthesiol, Dept Anesthesiol & Pain Med, Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
CELL METABOLISM | 2005年 / 2卷 / 06期
关键词：
D O I：
10.1016/j.cmet.2005.11.009
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：339 / 339
页数：1
相关论文
共 50 条
  • [21] Cardiovascular Risk Associated With NSAIDs and COX-2 Inhibitors
    Perry, Laura A.
    Mosier, Charles
    Atkins, Ashton
    Minehart, Megan
    US PHARMACIST, 2014, 39 (03) : 35 - 38
  • [22] NSAIDs curb oral cancer, but boost cardiovascular disease risk
    不详
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 2005, 136 (12) : 1650 - +
  • [23] Cardiovascular safety of NSAIDs
    Ray, Wayne A.
    BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
  • [24] Cardiovascular safety of NSAIDs
    Harbin, Megan
    Turgeon, Ricky D.
    Kolber, Michael R.
    CANADIAN FAMILY PHYSICIAN, 2014, 60 (03) : E166 - E166
  • [25] NSAIDs and cardiovascular health
    Gibofsky, Allan
    Simon, Lee S.
    White, William B.
    POSTGRADUATE MEDICINE, 2006, : 28 - 44
  • [26] NSAIDs and cardiovascular disease
    Patrignani, Paola
    Capone, Marta L.
    Tacconelli, Stefania
    HEART, 2008, 94 (04) : 395 - 397
  • [27] Cyclo-oxygenase 2 inhibitors, NSAIDs, and the risk of cardiovascular events
    Daniel H Solomon
    Nature Clinical Practice Rheumatology, 2006, 2 : 586 - 587
  • [28] No Obvious Extra Cardiovascular Risk Associated With Low-Dose NSAIDs
    Moore, N.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (06) : 600 - 601
  • [29] Cardiovascular risk factors at baseline in users of coxibs compared to users of NSAIDs
    De Jong, RB
    Breekveldt-Postma, NS
    Goettsch, WG
    Herings, RM
    VALUE IN HEALTH, 2005, 8 (03) : 241 - 241
  • [30] What is the impact of cardiovascular and renal complications on the benefit/risk ratio of the NSAIDs?
    Chaussade, Stanislas
    Avouac, Bernard
    Vicaut, Eric
    PRESSE MEDICALE, 2006, 35 (09): : 61 - 68
12345